Author

Tineke Jorritsma

Amsterdam UMC Location University of Amsterdam

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:mechanistic / dynamical model· 1

Frequent Co-Authors

S. Marieke van HamiD· 2 shared Amélie V. Bos· 1 shared Anja ten BrinkeiD· 1 shared Anouk T. Pappot· 1 shared Antonius A. de WaardiD· 1 shared Arie Johan HoogendijkiD· 1 shared Eileen W StalmaniD· 1 shared Filip EftimoviD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

S. Marieke van HamORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Characterization of a heterogenous activated B cell compartment arising early after antigen exposure preceding long-lived memory B cell formation

Laura Fernández Blanco, Lisan H Kuijper, Laura Y. L. Kummer, Niels J. M. Verstegen, Amélie V. Bos, Mathieu A. F. Claireaux, Mariël C Duurland, Tineke Jorritsma, Maurice Steenhuis, Gius Kerster, Juan Jesús García-Vallejo, Marit J. van Gils, Koos P J van Dam, Eileen W Stalman, Luuk Wieske, , of T2B! Immunity Against SARS‐CoV‐2 Study Group

The paper characterizes early antigen-specific B cell responses after vaccination, identifying distinct clusters with different contraction dynamics and potential roles in memory B cell formation.

European Journal of Immunology · Mar 1, 2026Peer-reviewedImmunology

Tumor-expressed SPPL3 supports innate anti-tumor immune responses.

Tamara Verkerk, Antonius A. de Waard, Sofie J. I. Koomen, Jasper Sanders, Tineke Jorritsma, Anouk T. Pappot, Nordin D. Zandhuis, Tao Zhang, Manfred Wuhrer, Arie Johan Hoogendijk, Floris P. J. van Alphen, Maartje van den Biggelaar, Hannes S. J. Stockinger, Klaas P. J. M. van Gisbergen, Robbert M. Spaapen, S. Marieke van Ham

This study shows that SPPL3 in tumor cells affects innate immune responses by modulating nsGSLs, reducing susceptibility to neutrophils, NK cells, and γδ T cells.

European Journal of Immunology · Dec 10, 2024Peer-reviewedImmunology